Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 7,876 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Med-eMonitor, PharmCAT, Treatment as Usual; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 60 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Myopia
Interventions: WaveLight EX500 excimer laser system with InnovEyes sightmap, LASIK, InnovEyes sightmap; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 9
States / cities: San Diego, California • Indianapolis, Indiana • Chevy Chase, Maryland + 6 more

Conditions: Wounds and Injuries
Interventions: Processed Amniotic Fluid, Standard of Care Wound Treatment Regimen; Drug · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Anesthesia
Interventions: Lidocaine; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 30 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Liver Transplant
Interventions: Everolimus, Tacrolimus (continued reduction), Tacrolimus (maintain 50% reduction); Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 12
States / cities: Phoenix, Arizona • Los Angeles, California • San Diego, California + 9 more

Conditions: Stroke, Acute
Interventions: Analyze plasma free fatty acid in blood; Diagnostic Test
Lead sponsor: Sanford Health; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Depression, Anxiety, Palliative Care, Caregivers, Cancer
Interventions: Problem-Solving Therapy, Attention-matched Control, In-depth interviews; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 532 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Columbia, Missouri • St Louis, Missouri • Philadelphia, Pennsylvania

Conditions: Anesthesia, Sedation and Analgesia, Interventional Radiology
Interventions: ketamine, Fentanyl (IV), Midazolam; Drug
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Insomnia Disorder
Interventions: Cognitive Behavioral Therapy for Insomnia (CBT-I), Passive Body Heating (PBH); Behavioral · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pain
Interventions: Transitional Pain Service; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking
Interventions: IVR intervention, IVR control; Behavioral
Lead sponsor: Consumer Wellness Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 2,985 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Dystrophica
Interventions: No intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Body Dysmorphic Disorders
Interventions: Crooked Mirror Externalization Therapy, Mirror Retraining Method; Behavioral
Lead sponsor: Westwood Institute for Anxiety Disorders, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2007
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Endometrial Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 55 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder, Suicidal Ideation
Interventions: Magnetic e-Resonance Therapy (MeRT), Ibogaine Hydrochloride with Magnesium Sulfate, 5-methoxy-N,N-dimethyltryptamine, Physiological Supplementation; Device · Drug
Lead sponsor: Axial Therapeutic Research; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Northridge, California

Conditions: Arthroplasty, Replacement, Hip
Interventions: Functional Movement Retraining; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Hypoxia
Interventions: Vasoconstrictor Agents, Head/neck repositioning, Increase ETCO2, IV fluid bolus, Additional anesthesia, RBC transfusion, Increase FiO2; Drug · Other · Biological
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiac Catheter Ablation, Atrial Flutter, Cardiac Arrhythmias
Interventions: Data Collection During Atrial Flutter Ablation; Other
Lead sponsor: David B. De Lurgio; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: HIV
Interventions: Cognitive Behavioral Therapy techniques; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Knee Osteoarthritis
Interventions: DA/MI Intervention, an educational program (an NIH-developed booklet); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years and older
Enrollment: 493 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alzheimer Disease, Alzheimer Dementia, Frontotemporal Dementia
Interventions: Spectral-Domain Optical Coherence Tomography (SD-OCT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Comprehensive Ophthalmic Examination, Fundus Photography; Device · Diagnostic Test
Lead sponsor: University of Michigan; Other
Eligibility: 45 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hematologic Malignancy
Interventions: Tacrolimus, Methotrexate, Tocilizumab; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Weakness, Hospital Acquired Condition
Interventions: Ambulation; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 60 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Non Small Cell Lung Cancer (NSCLC)
Interventions: Dacomitinib, Doxycycline, Probiotic, Alclometasone cream; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 79
States / cities: Duarte, California • Fullerton, California • Irvine, California + 49 more

Search by objective public record fields.

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap

Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds

Clinical Outcomes Maxilla: Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke

Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care

Prospective IR-led Sedation Feasibility

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2

Prospective Randomized Study of TPS + CBT VS TPS Alone: Readmission, Opioid Use, and Chronic Pain

Tobacco Quit Line Re-enrollments for the Underserved

A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Trifecta Research Study

Functional Movement Retraining After Hip Replacement

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals

Addressing Discrimination and Mistrust Among Black Men: Phase III

Race and Preference for Knee Replacement: A Patient-Centered Intervention

Multimodal Ocular Imaging in Neurodegeneration

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO